欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
ZT-12-037-01_2328073-61-4_产品详情
2328073-61-4
  • names:

    ZT-12-037-01

  • CAS号:

    2328073-61-4

    MDL Number:
  • MF(分子式): C21H31N5O2 MW(分子量): 385.5
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
ZT-12-037-01
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM004318-10mg 10mg ¥ 1890.00 ¥ 1890.00 Backorder
- +
¥ 0.00
YZM004318-5mg 5mg >97% ¥ 1040.00 ¥ 1040.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 2328073-61-4
Inchi
InchiKey
分子式 Formula C21H31N5O2
分子量 Molecular Weight 385.5
溶解度Solubility 生物体外In Vitro:DMSO溶解度8.33 mg/mL(21.61 mM;Need ultrasonic)
性状
储藏条件 Storage conditions 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description.
ZT-12-037-01(CAS:2328073-61-4)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 ZT-12-037-01 为靶向选择性丝氨酸/苏氨酸激酶STK19抑制剂,与 STK19 蛋白具有高亲和力相互作用,抑制 NRAS 驱动的黑素细胞恶性转化
IntroductionZT2371 is a STK19argeted inhibitor, has a highffinity interaction with STK19 protein and inhibits oncogenic NRASriven melanocyte malignant transformation. ZT2371 is anATPompetitive inhibitor, inhibiting phosphorylation of NRAS (major isof orm of Ras family) with anIC50of 24 nM.
Application1
Application2
Application3
ZT-12-037-01 为靶向选择性丝氨酸/苏氨酸激酶STK19抑制剂,与 STK19 蛋白具有高亲和力相互作用,抑制 NRAS 驱动的黑素细胞恶性转化。ZT-12-037-01 为ATP竞争性抑制剂,可以抑制 NRAS 的磷酸化,IC50为24 nM。ZT-12-037-01 is a STK19-targeted inhibitor, has a high-affinity interaction with STK19 protein and inhibits oncogenic NRAS-driven melanocyte malignant transformation. ZT-12-037-01 is anATP-competitive inhibitor, inhibiting phosphorylation of NRAS (major isoform of Ras family) with anIC50of 24 nM[1].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Yin C, et al. Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis. Cell. 2019 Feb 21;176(5):1113-1127.e16.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents